{"product_id":"xolid-infusion-200mg-400mg-600mg-intravenous-oxazolidinone-antibacterial-solution","title":"Xolid Infusion (200mg \u0026 400mg \u0026 600mg) - Intravenous Oxazolidinone Antibacterial Solution","description":"\u003ch4\u003eProduct Overview\u003c\/h4\u003e\r\\n\u003cp data-path-to-node=\"12\"\u003e\u003cb data-path-to-node=\"12\" data-index-in-node=\"0\"\u003eXolid Infusion\u003c\/b\u003e is a broad-spectrum, synthetic oxazolidinone parenteral formulation containing \u003cb data-path-to-node=\"12\" data-index-in-node=\"94\"\u003eLinezolid (2mg\/ml in an isotonic aqueous vehicle)\u003c\/b\u003e. Formulated for slow Intravenous (IV) infusion, Xolid provides immediate 100% systemic bioavailability for hospitalized or critically ill patients unable to take oral medications. It is indicated for the treatment of severe, complicated Gram-positive bacterial infections, including \u003cb data-path-to-node=\"12\" data-index-in-node=\"427\"\u003eMethicillin-Resistant \u003ci data-path-to-node=\"12\" data-index-in-node=\"449\"\u003eStaphylococcus aureus\u003c\/i\u003e (MRSA)\u003c\/b\u003e, \u003cb data-path-to-node=\"12\" data-index-in-node=\"479\"\u003eVancomycin-Resistant \u003ci data-path-to-node=\"12\" data-index-in-node=\"500\"\u003eEnterococcus faecium\u003c\/i\u003e (VRE)\u003c\/b\u003e, nosocomial and community-acquired pneumonia, and complicated skin and skin structure infections (cSSSI).\u003c\/p\u003e\r\\n\r\\n\u003ch3 data-path-to-node=\"13\"\u003eKey Benefits\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"14\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"14,0,0\"\u003e\u003cb data-path-to-node=\"14,0,0\" data-index-in-node=\"0\"\u003eParenteral Critical Care Solution:\u003c\/b\u003e Delivers immediate, predictable blood concentrations required for severe inpatient Gram-positive infections.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"14,1,0\"\u003e\u003cb data-path-to-node=\"14,1,0\" data-index-in-node=\"0\"\u003eGold-Standard VRE \u0026amp; MRSA Coverage:\u003c\/b\u003e Highly effective against multi-drug resistant pathogens where traditional antibiotics like penicillins or cephalosporins fail.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"14,2,0\"\u003e\u003cb data-path-to-node=\"14,2,0\" data-index-in-node=\"0\"\u003eEarly-Stage Protein Synthesis Inhibition:\u003c\/b\u003e Features a unique molecular target that minimizes cross-resistance with other major antibiotic classes.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"14,3,0\"\u003e\u003cb data-path-to-node=\"14,3,0\" data-index-in-node=\"0\"\u003eReady-to-Use Premixed Infusion:\u003c\/b\u003e Supplied in a pre-formulated isotonic infusion bag\/bottle, reducing clinical preparation time and contamination risk.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"14,4,0\"\u003e\u003cb data-path-to-node=\"14,4,0\" data-index-in-node=\"0\"\u003eSmooth Transition to Oral Therapy:\u003c\/b\u003e Demonstrates bioequivalent exposure that allows a seamless switch to oral Xolid tablets or suspension once the patient stabilizes.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"15\"\u003eHow It Works\u003c\/h3\u003e\r\\n\u003cp data-path-to-node=\"16\"\u003eXolid Infusion (Linezolid) exerts its antibacterial action by selectively binding to the \u003cb data-path-to-node=\"16\" data-index-in-node=\"89\"\u003e23S ribosomal RNA\u003c\/b\u003e of the 50S subunit on the bacterial ribosome. This action prevents the assembly of the functional \u003cb data-path-to-node=\"16\" data-index-in-node=\"205\"\u003e70S initiation complex\u003c\/b\u003e, which is essential for translating messenger RNA (mRNA) into vital bacterial proteins. By blocking protein synthesis at this early stage, Xolid halts bacterial replication, reduces toxin production, and eradicates multi-drug resistant Gram-positive pathogens.\u003c\/p\u003e\r\\n\r\\n\u003ch2 data-path-to-node=\"18\"\u003eWooCommerce Attribute \/ Variation Details\u003c\/h2\u003e\r\\n\u003ch3 data-path-to-node=\"19\"\u003eVariation 1: XOLID INFUSION 200MG (200mg\/100ml)\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"20\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,0,0\"\u003e\u003cb data-path-to-node=\"20,0,0\" data-index-in-node=\"0\"\u003eSKU:\u003c\/b\u003e \u003ccode data-path-to-node=\"20,0,0\" data-index-in-node=\"5\"\u003eXOL-INF-200\u003c\/code\u003e\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,1,0\"\u003e\u003cb data-path-to-node=\"20,1,0\" data-index-in-node=\"0\"\u003eShort Description:\u003c\/b\u003e Designed for pediatric intravenous dosing, weight-adjusted inpatient regimens, and step-down dose titration.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,2,0\"\u003e\u003cb data-path-to-node=\"20,2,0\" data-index-in-node=\"0\"\u003eKey Active Ingredient:\u003c\/b\u003e Linezolid — 200mg per 100ml ready-to-use infusion solution (2mg\/ml).\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,3,0\"\u003e\u003cb data-path-to-node=\"20,3,0\" data-index-in-node=\"0\"\u003eTarget Indications:\u003c\/b\u003e Pediatric MRSA\/VRE infections, weight-based pediatric pneumonia management, and targeted inpatient care.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,4,0\"\u003e\u003cb data-path-to-node=\"20,4,0\" data-index-in-node=\"0\"\u003eStandard Dosing:\u003c\/b\u003e Administered via slow IV infusion over 30 to 120 minutes every 8 to 12 hours based on pediatric weight guidelines (typically 10mg\/kg).\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"21\"\u003eVariation 2: XOLID INFUSION 400MG (400mg\/200ml)\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"22\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"22,0,0\"\u003e\u003cb data-path-to-node=\"22,0,0\" data-index-in-node=\"0\"\u003eSKU:\u003c\/b\u003e \u003ccode data-path-to-node=\"22,0,0\" data-index-in-node=\"5\"\u003eXOL-INF-400\u003c\/code\u003e\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"22,1,0\"\u003e\u003cb data-path-to-node=\"22,1,0\" data-index-in-node=\"0\"\u003eShort Description:\u003c\/b\u003e Formulated for adolescent dosing, adult weight-adjusted parenteral regimens, and moderate-to-severe inpatient infections.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"22,2,0\"\u003e\u003cb data-path-to-node=\"22,2,0\" data-index-in-node=\"0\"\u003eKey Active Ingredient:\u003c\/b\u003e Linezolid — 400mg per 200ml ready-to-use infusion solution (2mg\/ml).\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"22,3,0\"\u003e\u003cb data-path-to-node=\"22,3,0\" data-index-in-node=\"0\"\u003eTarget Indications:\u003c\/b\u003e Nosocomial pneumonia, complicated skin and soft tissue structure infections, VRE bacteremia, and MRSA sepsis.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"22,4,0\"\u003e\u003cb data-path-to-node=\"22,4,0\" data-index-in-node=\"0\"\u003eStandard Dosing:\u003c\/b\u003e Administered via slow IV infusion over 30 to 120 minutes every 12 hours as prescribed by an attending infectious disease specialist.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch2 data-path-to-node=\"24\"\u003eGeneral Product Details (Shared across variations)\u003c\/h2\u003e\r\\n\u003ch3 data-path-to-node=\"25\"\u003eKey Active Ingredients\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"26\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"26,0,0\"\u003e\u003cb data-path-to-node=\"26,0,0\" data-index-in-node=\"0\"\u003eLinezolid (200mg \/ 400mg per infusion bottle):\u003c\/b\u003e Synthetic parenteral oxazolidinone antibacterial agent that blocks bacterial 70S ribosomal initiation.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"27\"\u003eDirections for Use\u003c\/h3\u003e\r\\n\u003col start=\"1\" data-path-to-node=\"28\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"28,0,0\"\u003e\u003cb data-path-to-node=\"28,0,0\" data-index-in-node=\"0\"\u003eAdministration Route:\u003c\/b\u003e Strictly for \u003cb data-path-to-node=\"28,0,0\" data-index-in-node=\"35\"\u003eIntravenous (IV) Infusion\u003c\/b\u003e. Do NOT administer via intramuscular or intravenous push\/bolus injection.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"28,1,0\"\u003e\u003cb data-path-to-node=\"28,1,0\" data-index-in-node=\"0\"\u003eInfusion Rate:\u003c\/b\u003e Administer the premixed infusion solution slowly over a period of \u003cb data-path-to-node=\"28,1,0\" data-index-in-node=\"81\"\u003e30 to 120 minutes\u003c\/b\u003e.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"28,2,0\"\u003e\u003cb data-path-to-node=\"28,2,0\" data-index-in-node=\"0\"\u003eCompatibility:\u003c\/b\u003e Do not add supplementary medications to the infusion solution. If the same intravenous line is used for sequential infusion of other drugs, flush the line before and after Xolid infusion with a compatible solution (e.g., 0.9% Sodium Chloride or 5% Dextrose).\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"28,3,0\"\u003e\u003cb data-path-to-node=\"28,3,0\" data-index-in-node=\"0\"\u003eProfessional Healthcare Use:\u003c\/b\u003e Must be administered exclusively by qualified healthcare personnel in a hospital, clinic, or emergency setting.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ol\u003e\r\\n\u003ch3 data-path-to-node=\"29\"\u003ePrecautions\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"30\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"30,0,0\"\u003e\u003cb data-path-to-node=\"30,0,0\" data-index-in-node=\"0\"\u003ePrescription-Only Parenteral:\u003c\/b\u003e For inpatient hospital and critical care administration only; strictly prohibited for self-administration.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"30,1,0\"\u003e\u003cb data-path-to-node=\"30,1,0\" data-index-in-node=\"0\"\u003eReversible MAO Inhibition Warning:\u003c\/b\u003e Linezolid is a reversible, non-selective Monoamine Oxidase (MAO) inhibitor. Avoid co-administration with serotonergic drugs (SSRIs, SNRIs, tricyclic antidepressants) to prevent serotonin syndrome.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"30,2,0\"\u003e\u003cb data-path-to-node=\"30,2,0\" data-index-in-node=\"0\"\u003eHematologic Monitoring:\u003c\/b\u003e Reversible myelosuppression (anemia, leukopenia, pancytopenia, and thrombocytopenia) may occur, especially with therapy exceeding 14 days. Monitor complete blood counts (CBC) weekly.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"30,3,0\"\u003e\u003cb data-path-to-node=\"30,3,0\" data-index-in-node=\"0\"\u003eNeuropathy Risk:\u003c\/b\u003e Peripheral and optic neuropathy have been reported primarily in patients treated for longer than 28 days.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"30,4,0\"\u003eConsult an attending physician before use during pregnancy or lactation.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"30,5,0\"\u003eKeep out of reach of children.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"31\"\u003eStorage Instructions\u003c\/h3\u003e\r\\n\u003cp data-path-to-node=\"32\"\u003eStore in a cool, dry place below 30°C. Protect from direct sunlight, excessive heat, and freezing. Retain in its protective overwrap\/carton until administration. Inspect for clarity and absence of particulate matter prior to use.\u003c\/p\u003e\r\\n\r\\n\u003ch3 data-path-to-node=\"33\"\u003eManufacturer Information\u003c\/h3\u003e\r\\n\u003cp data-path-to-node=\"34\"\u003eFormulated and manufactured in strict compliance with international pharmaceutical quality standards, committed to advancing parenteral anti-infective therapies that combat multi-drug resistant bacterial pathogens and support critical care recovery.\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":44164491214907,"sku":null,"price":0.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0695\/4899\/8715\/files\/XOLID-200-INF.jpg?v=1789027899","url":"https:\/\/pharmaservicesgroup.com\/products\/xolid-infusion-200mg-400mg-600mg-intravenous-oxazolidinone-antibacterial-solution","provider":"Pharma Services Distribution","version":"1.0","type":"link"}